Volume 30, Supplement—October 2024
SUPPLEMENT ISSUE
Articles
Serosurveillance for Plasmodium falciparum Malaria in Peruvian Army Peacekeeping Personnel, Central African Republic, 2021–2022
Julio A. Ventocilla, Hugo O. Valdivia, Marianela Ore, Rocio Santos, Edson Maguina, Danielle L. Pannebaker, Aida M. Delgado-Flores, and Juan F. Sanchez
Table 1
Demographic, clinical, and laboratory characteristics of 129 participants in study of serosurveillance for Plasmodium falciparum malaria in Peruvian Army peacekeeping personnel, Central African Republic, 2021–2022*
| Characteristic | Value |
|---|---|
| Demographics |
|
| Sex | |
| M | 119 (92.2) |
| F |
10 (7.7) |
| Mean age, y (SD) |
42.4 (7.4) |
| Rank | |
| Enlisted | 33 (25.6) |
| Warrant officers | 74 (57.4) |
| Officers |
22 (17.0) |
| Clinical | |
| Malaria diagnosed in CAR | 43 (33.3) |
| No. malaria episodes, n = 43 | |
| 1 | 34 (79.1) |
| 2 | 7 (16.3) |
| 3 | 1 (2.3) |
| 4 | 1 (2.3) |
| Malaria diagnosed in Peru | 4 (3.1) |
| Hospitalization required |
2 (50.0) |
| Laboratory, n = 97 | |
| OD values against P. falciparum MSP1-19 | |
| Mean (SD) | 0.17 (0.31) |
| Median (IQR) | 0.08 (0.07–0.12) |
| Seroprevalence to P. falciparum MSP1-19 | |
| Positive | 31 (31.9) |
| Negative | 66 (68.1) |
*Values are no. (%) except as indicated. CAR, Central African Republic; IQR, interquartile range; MSP1-19, C-terminal 19-kDa region merozoite surface protein 1; OD, optical density.
Page created: September 05, 2024
Page updated: November 11, 2024
Page reviewed: November 11, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.